This bill creates federal grants for local health departments and tribal organizations in the 50 U.S. counties with the highest infant mortality rates. It funds 5-year pilot programs focused on reducing infant deaths by addressing causes like preterm birth, maternal complications, and sudden infant death through targeted outreach, postpartum care, and services such as smoking cessation and nutrition support. Grantees must develop community-specific plans, establish rural outreach, and conduct public education campaigns on preventing preterm births. The program requires annual reports on outcomes and allocates $10 million annually from 2025 through 2029 for these initiatives.
S 3712, the "BO's Act," requires the U.S. Department of Health and Human Services to study home cardiorespiratory monitors used for infants, particularly high-risk babies, to assess their effectiveness in preventing sudden unexpected infant death. The bill mandates a report to Congress within one year of enactment, detailing monitor accuracy, new home sleep care models, insurance coverage criteria, and recommendations on whether these devices should be covered by public or private health plans. This legislation directly affects infants (especially high-risk cases), healthcare providers, and insurance companies by initiating a federal review of current practices. The bill does not create new laws or funding but establishes a data-gathering process to inform future policy decisions about infant monitoring devices.
This bill requires most health insurance plans, Medicare Part D, Medicaid, and CHIP to cover vaccines recommended by the CDC's Advisory Committee on Immunization Practices (ACIP) without cost-sharing (like copays or deductibles). It applies to vaccines recommended as of October 25, 2024, including updates through 2029, and covers all such vaccines for the period starting when the bill is enacted until December 31, 2029. The requirement excludes vaccines given within minimum recommended intervals. It directly affects patients, insurers, and government health programs by ensuring no out-of-pocket costs for covered vaccines during this timeframe.
The Infant Formula Made in America Act of 2025 creates two tax credits to incentivize domestic infant formula production. It offers a 30% investment credit for manufacturers who build or expand facilities to make U.S.-made infant formula (with a total credit cap of $750 million), plus a $2 per pound production credit for formula sold in the U.S. (capped at 18 million pounds annually). The credits are limited to manufacturers with global revenue under $750 million and require at least 50% of formula produced with the investment credit to be sold within the U.S. within one year. The bill includes recapture provisions if manufacturers fail to meet these requirements, and applies to facilities starting construction after the bill's enactment.
HR 4074, the Optimizing Postpartum Outcomes Act of 2025, requires the Health and Human Services Secretary to issue guidance within one year on improving Medicaid and CHIP coverage for pelvic health services during pregnancy and the postpartum period (defined as up to 6 months after birth or during lactation). The bill directs the GAO to study coverage gaps for these services and mandates a new CDC-led education campaign to train healthcare providers and inform postpartum women about pelvic floor exams and physical therapy. Key provisions include standardizing terminology for pelvic health conditions, sharing state best practices for payment models, and authorizing $2 million annually for the education program through 2030. This bill directly affects postpartum women covered by Medicaid or CHIP by aiming to increase access to evidence-based pelvic health care.
This bill changes how state agencies purchase infant formula for the WIC program. It requires selecting two manufacturers through competitive bidding (instead of one) and designates one as primary and one as secondary for each state's contract. This aims to improve supply chain reliability and access for WIC participants - low-income pregnant women, infants, and children. The policy directly affects all states administering WIC formula contracts under the Child Nutrition Act.
The Hospice Recertification Flexibility Act extends the ability for hospice providers to use telehealth for patient recertifications (verifying ongoing eligibility for hospice care) until December 31, 2027, instead of ending in March 2025. It specifies that telehealth recertifications will not apply in certain cases starting January 1, 2026, such as when patients are in areas with a hospice enrollment moratorium or when providers are under enhanced oversight. The bill also requires hospice claims for telehealth recertifications on or after January 1, 2026, to include a specific modifier or code indicating the telehealth encounter. This change directly affects hospice providers and their patients by modifying how remote eligibility checks are processed under Medicare.
S 3799, the Healthy Start Reauthorization Act of 2026, extends annual funding for the Healthy Start Initiative through fiscal years 2026 to 2030. The bill amends existing law to specify $145 million in annual funding for this program, which provides prenatal and infant health services to at-risk communities. This reauthorization directly affects the Healthy Start Initiative programs nationwide, ensuring continued support for maternal and infant health services. The key provision is the fixed annual funding level, replacing prior language about appropriations.
The Kidd's Stuttering Act requires Medicaid and CHIP to screen children aged 2-6 for stuttering and speech fluency during routine well-child visits starting January 1, 2027. It also mandates that Medicaid and CHIP cover specified speech therapy services for childhood stuttering (defined as "specified speech therapy services") with coverage rules no more restrictive than those for other speech disorders like language delays. The bill ensures these services include telehealth options and applies to all states administering Medicaid or CHIP. This directly affects children with stuttering who qualify for Medicaid or CHIP, aiming to improve early detection and access to treatment.
This bill amends the SUPPORT for Patients and Communities Act to expand substance abuse and suicide prevention services for children, adolescents, and young adults (up to age 25). It requires eligible providers - like pediatric specialists, emergency departments, and children’s hospitals - to offer parents or guardians counseling on preventing overdose/suicide and provide supplies to reduce access to lethal means (e.g., safe storage containers). The bill allocates at least $2 million annually in grants to fund these prevention programs through eligible entities, with funding authorized for fiscal years 2026-2030. It directly affects young people at risk of substance misuse or self-harm and their caregivers.
